ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
Abstract: Vision Transformers (ViTs) have computational costs scaling quadratically with the number of tokens, calling for effective token pruning policies. Most existing policies are handcrafted, ...